Meinhold-Heerlein IM - Search Results

1

Two-dimensional gel electrophoresis in peritoneal fluid samples identifies differential protein regulation in patients suffering from peritoneal or ovarian endometriosis.

Wölfler MM, Meinhold-Heerlein IM, Söhngen L, Rath W, Knüchel R, Neulen J, Maass N, Henkel C. Wölfler MM, et al. Among authors: meinhold heerlein im. Fertil Steril. 2011 Jun 30;95(8):2764-8. doi: 10.1016/j.fertnstert.2011.03.061. Epub 2011 Apr 16. Fertil Steril. 2011. PMID: 21497343 Free article.

2

Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency.

von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Meinhold-Heerlein I, Brand-Saberi B. von Kaisenberg CS, et al. Hum Reprod. 2003 Dec;18(12):2544-61. doi: 10.1093/humrep/deg499. Hum Reprod. 2003. PMID: 14645170

3

[Benign and borderline tumors of the ovary].

Schem Ch, Bauerschlag DO, Meinhold-Heerlein I, Fischer D, Friedrich M, Maass N. Schem Ch, et al. Ther Umsch. 2007 Jul;64(7):369-74. doi: 10.1024/0040-5930.64.7.369. Ther Umsch. 2007. PMID: 17948753 Review. German.

4

Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.

Alkasi O, Meinhold-Heerlein I, Zaki R, Fasching P, Maass N, Jonat W, Beckmann MW. Alkasi O, et al. Arch Gynecol Obstet. 2009 Jan;279(1):57-60. doi: 10.1007/s00404-008-0631-6. Epub 2008 Apr 1. Arch Gynecol Obstet. 2009. PMID: 18379806

5

Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.

Mundhenke C, Weigel MT, Sturner KH, Roesel F, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Hilpert F, Jonat W, Maass N. Mundhenke C, et al. J Cancer Res Clin Oncol. 2008 Dec;134(12):1397-405. doi: 10.1007/s00432-008-0408-0. Epub 2008 May 9. J Cancer Res Clin Oncol. 2008. PMID: 18465140

6

Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.

Weigel MT, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Bauer M, Jonat W, Maass N, Mundhenke C. Weigel MT, et al. Cancer Lett. 2009 Jan 8;273(1):70-9. doi: 10.1016/j.canlet.2008.07.040. Epub 2008 Sep 21. Cancer Lett. 2009. PMID: 18809244

7

Actual management of ductal carcinoma in situ of the breast.

Maass N, Alkasi O, Bauer M, Jonat W, Souchon R, Meinhold-Heerlein I. Maass N, et al. Arch Gynecol Obstet. 2009 Nov;280(5):699-705. doi: 10.1007/s00404-009-0999-y. Epub 2009 Mar 4. Arch Gynecol Obstet. 2009. PMID: 19259692 Review.

8

The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.

Bauerschlag DO, Schem C, Weigel MT, Von Kaisenberg C, Strauss A, Bauknecht T, Maass N, Meinhold-Heerlein I. Bauerschlag DO, et al. J Cancer Res Clin Oncol. 2010 Jan;136(1):79-88. doi: 10.1007/s00432-009-0639-8. J Cancer Res Clin Oncol. 2010. PMID: 19609560

9

Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.

Bräutigam K, Bauerschlag DO, Weigel MT, Biernath-Wüpping J, Bauknecht T, Arnold N, Maass N, Meinhold-Heerlein I. Bräutigam K, et al. Transl Oncol. 2009 Aug 18;2(3):164-73. doi: 10.1593/tlo.09121. Transl Oncol. 2009. PMID: 19701501 Free PMC article.

10

Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer.

Bauerschlag DO, Habermann M, Weimer J, Meinhold-Heerlein I, Hilpert F, Weigel M, Bauer M, Mundhenke C, Jonat W, Maass N, Schem C. Bauerschlag DO, et al. Anticancer Res. 2010 Jul;30(7):2739-44. Anticancer Res. 2010. PMID: 20683007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters